In this issue, prominent Polish experts and researchers present the news on pathomorphological diagnosis of neuroendocrine tumors, the role of activation of insulin-like growth factors in colorectal cancer, the importance of hypothyroidism related to cabozantinib and the problems of pneumonia after hematopoietic stem cell transplantation. Finally, there is the focus on the benefit of BRAF/MEK inhibitors in advanced skin melanoma and lapatinib in breast cancer.
Editor-in-Chief Deputy Editor-in-Chief
Sebastian Szmit, MD, PhD Eric E. Harrison, MD
Assistant Professor Associate Professor, Fellow of ACC, AHA, ASAI, ACP